INDIANAPOLIS, Ind. (ADAMS) – Eli Lilly and Company will acquire a genetic medicine company.
The Indianapolis-based company will buy Akouos for $487 million dollars. This is the second acquisition in gene therapy for Eli Lilly.
The deal is already approved by both companies boards of directors.
Read more here
